Ameriprise Financial Inc Meridian Bioscience Inc Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$31.15 - $33.39 $286,922 - $307,555	-9,211 Reduced 3.95%	224,041 $7.44 Million
Q3 2022 Nov 14, 2022	SELL	$30.9 - $33.55 $66,805 - $72,535	-2,162 Reduced 0.92%	233,252 $7.36 Million
Q2 2022 Aug 15, 2022	BUY	$23.75 - $31.69 $119,842 - $159,907	5,046 Added 2.19%	235,414 $7.16 Million
Q1 2022 May 16, 2022	SELL	$19.97 - $26.94 $84,373 - $113,821	-4,225 Reduced 1.8%	230,368 $5.98 Million
Q4 2021 Feb 14, 2022	BUY	$17.46 - $21.61 $70,084 - $86,742	4,014 Added 1.74%	234,593 $4.79 Million
Q3 2021 Nov 15, 2021	SELL	$17.35 - $22.5 $186,148 - $241,402	-10,729 Reduced 4.45%	230,579 $4.44 Million
Q2 2021 Aug 16, 2021	SELL	$18.01 - $28.32 $202,702 - $318,741	-11,255 Reduced 4.46%	241,308 $5.35 Million
Q1 2021 May 17, 2021	BUY	$19.76 - $29.89 $429,799 - $650,137	21,751 Added 9.42%	252,563 $6.63 Million
Q4 2020 Feb 12, 2021	SELL	$15.73 - $21.66 $330,361 - $454,903	-21,002 Reduced 8.34%	230,812 $4.31 Million
Q3 2020 Nov 16, 2020	SELL	$13.54 - $26.41 $19,402 - $37,845	-1,433 Reduced 0.57%	251,814 $4.28 Million
Q2 2020 Aug 14, 2020	SELL	$7.84 - $23.29 $68,278 - $202,832	-8,709 Reduced 3.32%	253,247 $5.9 Million
Q1 2020 May 15, 2020	SELL	$5.57 - $11.5 $1.27 Million - $2.61 Million	-227,197 Reduced 46.45%	261,956 $2.2 Million
Q4 2019 Feb 14, 2020	SELL	$7.9 - $10.14 $38,536 - $49,462	-4,878 Reduced 0.99%	489,153 $4.78 Million
Q3 2019 Nov 14, 2019	SELL	$9.17 - $12.01 $1.91 Million - $2.51 Million	-208,645 Reduced 29.69%	494,031 $4.69 Million
Q2 2019 Aug 14, 2019	BUY	$10.88 - $17.6 $2.25 Million - $3.65 Million	207,104 Added 41.79%	702,676 $8.35 Million
Q1 2019 May 15, 2019	BUY	$15.51 - $17.61 $1.56 Million - $1.77 Million	100,506 Added 25.44%	495,572 $8.73 Million
Q4 2018 Feb 14, 2019	SELL	$14.52 - $19.72 $190,633 - $258,903	-13,129 Reduced 3.22%	395,066 $6.86 Million
Q3 2018 Nov 14, 2018	BUY	$14.85 - $16.35 $642,470 - $707,366	43,264 Added 11.86%	408,195 $6.08 Million
Q2 2018 Aug 14, 2018	BUY	$13.8 - $16.8 $1.37 Million - $1.67 Million	99,282 Added 37.37%	364,931 $5.8 Million
Q1 2018 May 15, 2018	BUY	$13.8 - $16.2 $59,119 - $69,400	4,284 Added 1.64%	265,649 $3.77 Million
Q4 2017 Feb 12, 2018	SELL	$13.55 - $15.8 $31,286 - $36,482	-2,309 Reduced 0.88%	261,365 $3.66 Million
Q3 2017 Nov 07, 2017	BUY	$13.45 - $14.35 $3.55 Million - $3.78 Million	263,674	263,674 $3.77 Million

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account